Morgan Stanley Bullish on Dividend Stocks
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 8 hours ago
0mins
Source: CNBC
- Dividend Potential Analysis: Morgan Stanley highlights that companies initiating dividends outperform the market by an average of 650 basis points in the six months following the announcement and by 1,000 basis points in the subsequent 12 months, indicating a significant enhancement in investor returns, especially when dividends are reinvested for compounding benefits.
- Centene's Advantages: Centene boasts an 18% free cash flow yield and a net cash position exceeding 5% of its market cap, making it an ideal candidate for dividends; additionally, the company surpassed expectations for adjusted earnings per share and revenue in Q1, with its stock rising 44% this year.
- BioMarin's Acquisition Impact: BioMarin, with a net cash position of 7.6% of its market cap and a 10.4% free cash flow yield, successfully made the list after completing a $4.8 billion acquisition of Amicus Therapeutics, which is expected to significantly enhance its market share in rare metabolic diseases, although it slightly lowered its 2026 non-GAAP earnings per share guidance while raising its full-year revenue guidance to $3.825 to $3.925 billion.
- Deckers Outdoor's Growth Outlook: Deckers Outdoor posted better-than-expected results for its fiscal Q1, with a free cash flow yield of 6.7%, and analysts have rated the stock as a buy, anticipating that its portfolio of category-defining brands will drive future growth, with shares gaining nearly 10% this year.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CNC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CNC
Wall Street analysts forecast CNC stock price to fall
15 Analyst Rating
5 Buy
8 Hold
2 Sell
Hold
Current: 58.910
Low
32.00
Averages
43.07
High
59.00
Current: 58.910
Low
32.00
Averages
43.07
High
59.00
About CNC
Centene Corporation is a healthcare company. It provides access to quality healthcare; programs and a range of health solutions that help families and individuals get well. Its segments include Medicaid, Medicare, Commercial and Other. The Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Dividend Potential Analysis: Morgan Stanley highlights that companies initiating dividends outperform the market by an average of 650 basis points in the six months following the announcement and by 1,000 basis points in the subsequent 12 months, indicating a significant enhancement in investor returns, especially when dividends are reinvested for compounding benefits.
- Centene's Advantages: Centene boasts an 18% free cash flow yield and a net cash position exceeding 5% of its market cap, making it an ideal candidate for dividends; additionally, the company surpassed expectations for adjusted earnings per share and revenue in Q1, with its stock rising 44% this year.
- BioMarin's Acquisition Impact: BioMarin, with a net cash position of 7.6% of its market cap and a 10.4% free cash flow yield, successfully made the list after completing a $4.8 billion acquisition of Amicus Therapeutics, which is expected to significantly enhance its market share in rare metabolic diseases, although it slightly lowered its 2026 non-GAAP earnings per share guidance while raising its full-year revenue guidance to $3.825 to $3.925 billion.
- Deckers Outdoor's Growth Outlook: Deckers Outdoor posted better-than-expected results for its fiscal Q1, with a free cash flow yield of 6.7%, and analysts have rated the stock as a buy, anticipating that its portfolio of category-defining brands will drive future growth, with shares gaining nearly 10% this year.
See More
- Market Performance: The S&P 500 rose by 0.61% and the Nasdaq 100 increased by 1.76%, reaching all-time highs, indicating strong demand for tech stocks amid falling oil prices and progress in US-Iran peace talks.
- Oil Price Volatility: WTI crude oil prices fell to a 2.5-week low as US-Iran negotiations aimed at reopening the Strait of Hormuz progressed, although military actions by US Central Command pressured market sentiment, leading to declines in energy stocks.
- Economic Data Impact: The Chicago Fed National Activity Index rose to a 13-month high of 0.14, surpassing expectations, while a slight decline in the consumer confidence index reflects the complexities of economic recovery, potentially influencing future market trends.
- Earnings Reports: As of Tuesday, 83% of the 475 S&P 500 companies reported earnings above expectations, with Q1 earnings projected to grow by 12% year-on-year, although excluding the tech sector, the increase is only 3%, highlighting disparities across industries.
See More

- Customer Service Recognition: Health Net has been named one of America's Best Customer Service in Financial Services 2026, reflecting its outstanding performance in customer service, which enhances the company's reputation and competitive position in the healthcare industry.
- Consumer Feedback Basis: This award is based on direct feedback from U.S. consumers and includes 500 financial services companies, indicating Health Net's ongoing commitment to customer satisfaction and service quality, further solidifying its market position in California.
- Service Philosophy: Health Net views customer service as a core part of its mission, aiming to improve health outcomes and build trust through clear and empathetic communication, thereby enhancing customer loyalty.
- Investment in Training and Tools: The company continues to invest in comprehensive training and tools to ensure customer service representatives can deliver high-quality service experiences, and this member-centered approach helps improve customer satisfaction and long-term health outcomes.
See More

- Customer Service Recognition: Health Net has been named one of America's Best Customer Service in Financial Services 2026, reflecting its exceptional performance in customer service and enhancing its reputation in the competitive healthcare market.
- Consumer Feedback Basis: The recognition is based on over 57,000 customer survey responses and 660,000 customer reviews, ensuring a comprehensive and fair assessment that boosts Health Net's brand trust.
- Quality of Service Dimensions: The evaluation considered seven dimensions including professional competence and solution orientation, highlighting Health Net's commitment to delivering high-quality customer experiences and further solidifying its market position.
- Long-term Commitment: Health Net emphasizes that customer service is a core part of its mission, continuously investing in employee training and tools to ensure its customer service team can provide clear, empathetic, and practical solutions, thereby enhancing customer satisfaction and loyalty.
See More
- Strong Market Performance: The S&P 500 Index rose by 0.81% and the Nasdaq 100 Index increased by 1.74%, reaching all-time highs, indicating robust market support for technology stocks, particularly amid falling crude oil prices and declining bond yields.
- Mixed Economic Data: The Chicago Fed National Activity Index rose to a 13-month high of 0.14, surpassing expectations, while the S&P Composite-20 home price index increased by only 0.83% year-on-year, below the expected 0.90%, suggesting weakness in the housing market that could impact future consumer confidence.
- Volatile Oil Market: WTI crude oil prices fell to a 2.5-week low due to progress in US-Iran peace talks, although US Central Command's strikes on Iranian targets caused market fluctuations, highlighting the ongoing geopolitical influence on energy markets.
- Earnings Season Insights: So far, 83% of the 475 S&P 500 companies have beaten earnings estimates, with Q1 earnings projected to rise by 12% year-on-year; however, excluding the technology sector, the increase is only 3%, reflecting pressure on overall economic growth.
See More
- Healthcare ETF Performance: The Health Care Select Sector SPDR Fund ETF (XLV), which holds a 12.12% weight in the S&P 500, has declined 3.17% year-to-date, significantly underperforming the S&P 500's 9.17% gain, indicating weakness in the sector's current market position.
- Quant Rating System: Seeking Alpha's quant system rates large-cap healthcare companies (market cap over $10B) on a scale from 1 to 5, with scores above 3.5 classified as bullish and below 2.5 as bearish, providing investors with insights into potential opportunities within the sector.
- Top-Rated Stocks: Centene Corporation (CNC) leads with a quant rating of 4.96, classified as a Strong Buy, followed closely by BrightSpring Health Services (BTSG) at 4.91 and Jazz Pharmaceuticals (JAZZ) at 4.81, highlighting their strong growth and profitability potential.
- Bottom-Rated Stocks: CSL Limited (CSLLY) has a low quant rating of 1.14, categorized as a Strong Sell, with EssilorLuxottica (ESLOY) and Shionogi & Co. (SGIOY) also underperforming at 1.28, indicating significant challenges in their market competitiveness.
See More









